B-cell Acute Lymphoblastic Leukemia

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00531	Cyclophosphamide	0	Not Yet Recruiting	1
DB01073	Fludarabine	0	Not Yet Recruiting	1
DB01042	Melphalan	0	Not Yet Recruiting	1
DB12597	Asciminib	1	Recruiting	1
DB00531	Cyclophosphamide	1	Recruiting	1
DB00531	Cyclophosphamide	1	Unknown Status	1
DB00987	Cytarabine	1	Recruiting	1
DB01254	Dasatinib	1	Recruiting	1
DB00694	Daunorubicin	1	Recruiting	1
DB01234	Dexamethasone	1	Recruiting	1
DB00773	Etoposide	1	Recruiting	1
DB01073	Fludarabine	1	Recruiting	1
DB01073	Fludarabine	1	Unknown Status	1
DB05889	Inotuzumab ozogamicin	1	Recruiting	2
DB00563	Methotrexate	1	Recruiting	1
DB15721	Natural Killer Cell	1	Suspended	1
DB00059	Pegaspargase	1	Recruiting	1
DB00635	Prednisone	1	Recruiting	2
DB00073	Rituximab	1	Recruiting	1
DB11973	Tesevatinib	1	Recruiting	1
DB13881	Tisagenlecleucel	1	Unknown Status	1
DB06273	Tocilizumab	1	Recruiting	1
DB11581	Venetoclax	1	Recruiting	1
DB00541	Vincristine	1	Recruiting	1
DB00531	Cyclophosphamide	1 / 2	Active Not Recruiting	1
DB00531	Cyclophosphamide	1 / 2	Recruiting	1
DB01073	Fludarabine	1 / 2	Active Not Recruiting	1
DB01073	Fludarabine	1 / 2	Recruiting	1
DB06185	Forodesine	1 / 2	Completed	1
DB06273	Tocilizumab	1 / 2	Active Not Recruiting	1
DB09052	Blinatumomab	2	Completed	1
DB09052	Blinatumomab	2	Recruiting	3
DB09052	Blinatumomab	2	Withdrawn	1
DB13881	Tisagenlecleucel	2	Active Not Recruiting	1
DB13881	Tisagenlecleucel	2	Completed	1
DB13881	Tisagenlecleucel	2	Recruiting	1
DB13881	Tisagenlecleucel	2	Withdrawn	2
DB00541	Vincristine	2	Withdrawn	1
DB13881	Tisagenlecleucel	3	Recruiting	1